Abstract:The p53 tumor suppressor protein participates in multiple cellular processes including cell cycle checkpoints and programmed cell death. In cell lines, loss of p53 function is associated with increased genetic instability including aneuploidy, gene amplification, and point mutation. Although similar genetic instability often accompanies the progression of malignancy in tumors, its role in tumor initiation in normal cells is not clear. To study whether or not loss of p53 leads to genetic instability in normal cells in vive, we have examined mechanisms of loss of heterozygosity (LOH) at the Aprt (adenine phosphoribsyltransferase) and flanking loci in normal fibroblasts and T lymphocytes of p53-deficient mice. Somatic cell variants that arose in vivo as a consequence of genetic or epigenetic alterations abolishing Aprt function were selected and expanded in vitro by virtue of their resistance to 2,6-diaminopurine (DAP). We observed that p53 null mice produced about three times as many DAP-resistant fibroblast colonies than wild-type mice, but the frequency of DAP-resistant T lymphocyte colonies was not significantly changed. Mitotic recombination, but not point mutation, partly accounted for the increase in the frequency of DAP-resistant fibroblasts. Most significantly, chromosome loss/duplication and interstitial deletion, which were extremely rare events in the wild-type mice, represented a significant proportion of LOH events in both fibroblasts and T lymphocytes of p53 null mice. Also, increased interstitial deletion was observed in fibroblasts of p53 heterozygous mice. These data suggest that increased genetic variation, including chromosome instability, starts at the initiation stage of tumorigenesis when functional p53 is absent or reduced.

The Atm-P53 Pathway Suppresses Aneuploidy-Induced Tumorigenesis

ATM and P21 Cooperate to Suppress Aneuploidy and Subsequent Tumor Development.

Involvement of P53 and P21 in Cellular Defects and Tumorigenesis in Atm−/− Mice

Atm-Chk2-P53 Activation Prevents Tumorigenesis At An Expense Of Organ Homeostasis Upon Brca1 Deficiency

Loss of Spindle Assembly Checkpoint–mediated Inhibition of Cdc20 Promotes Tumorigenesis in Mice

P53 Gain-of-function Cancer Mutants Induce Genetic Instability by Inactivating ATM

Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression.

Partial Rescue of the Prophase I Defects of Atm-deficient Mice by P53 and P21 Null Alleles.

Chromosome Stability, in the Absence of Apoptosis, is Critical for Suppression of Tumorigenesis in Trp53 Mutant Mice

Impaired Skin And Mammary Gland Development And Increased Gamma-Irradiation-Induced Tumorigenesis In Mice Carrying A Mutation Of S1152-Atm Phosphorylation Site In Brca1

Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis

Data from Impaired Skin and Mammary Gland Development and Increased γ-Irradiation–Induced Tumorigenesis in Mice Carrying a Mutation of S1152-ATM Phosphorylation Site in Brca1

Identification of an Ataxia Telangiectasia-Mutated Protein Mediated Surveillance System to Regulate Bcl-2 Overexpression

Chromosome Instability Contributes To Loss Of Heterozygosity In Mice Lacking P53

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Gadd45a Deletion Aggravates Hematopoietic Stem Cell Dysfunction in ATM-deficient Mice.

Loss of p53-mediated cell-cycle arrest, senescence and apoptosis promotes genomic instability and premature aging

Phosphorylation of MAD2 at Ser195 Promotes Spindle Checkpoint Defects and Sensitizes Cancer Cells to Radiotherapy in ATM Deficient Cells

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

Ser18 and 23 Phosphorylation is Required for P53-Dependent Apoptosis and Tumor Suppression

Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis